logo

Merrimack Pharmaceuticals, Inc. (MACK)



Trade MACK now with
  Date
  Headline
11/5/2020 8:25:08 AM Merrimack Q3 Net Loss $1.0 Mln Or $0.08 Per Basic Share
8/7/2020 8:24:09 AM Merrimack Q2 Net Loss $1.2 Mln Or $0.09/Shr Vs Loss Of $9.4 mln Or $0.71/Shr Last Year
4/2/2020 8:44:54 AM Merrimack Divests Early Stage Asset For $2.25 Mln